|
WO2016115520A1
|
|
Methods for treating tauopathy
|
|
US2015343011A1
|
|
Treatment Of HIV-1 Infection And AIDS
|
|
WO2015167874A1
|
|
Inhibitors of jmjd2c as anticancer agents
|
|
WO2015095609A1
|
|
Inhibition of interferon-gamma-inducible protein 16 (ifi16)
|
|
US2016015759A1
|
|
Compositions and methods for treating an immunodeficiency virus infection
|
|
WO2014127148A1
|
|
Compositions and methods of use thereof for identifying anti-viral agents
|
|
US2015133434A1
|
|
Compositions and Methods for Reactivating Latent Immunodeficiency Virus
|
|
US2014303074A1
|
|
Compositions and Methods For Inhibiting Immunodeficiency Virus Transcription
|
|
WO2013033213A1
|
|
Methods for generating cardiomyocytes
|
|
WO2012067839A2
|
|
Methods of treating neurodegenerative disease
|
|
WO2012047852A2
|
|
Compositions and methods for modulating immunodeficiency virus transcription
|
|
WO2011139688A2
|
|
Methods for generating cardiomyocytes
|
|
WO2011109246A1
|
|
Antibody specific for apolipoprotein and methods of use thereof
|
|
US2011135611A1
|
|
Methods for treating apolipoprotein e4-associated disorders
|
|
US2011135613A1
|
|
Methods for treating apolipoprotein e4-associated disorders
|
|
WO2011059920A2
|
|
Methods of generating neural stem cells
|
|
MX2012005300A
|
|
Methods and compositions for modulating tau levels.
|
|
WO2011009064A1
|
|
Methods of controlling cell proliferation
|
|
WO2010104796A2
|
|
Methods of modulating smooth muscle cell proliferation and differentiation
|
|
CA2743913A1
|
|
Inhibition of apoe cleavage activity in the treatment of apoe-related disorders
|
